By
Hindustan Times
Published: Jan. 29, 2023, 3:03 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
New Delhi: The Indian Patent Office had held its final hearing on a challenge filed by two tuberculosis survivors to prevent the Indian arm of drugmaker Johnson & Johnson from extending its patent on bedaquiline, used against drug-resistant TB, beyond the primary patent’s expiry in July.
Read More →
By
Hindustan Times
Published: Dec. 10, 2018, 9:23 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access
The girl was brought to Mumbai in a state of being unable to breath and with an oxygen cylinder owing to scarring in her lungs. The extreme delay in treatment caused severe damage to her lungs, resulting in her death.
Read More →